• Nutraceuticals

(around 75 billion US $)

• Pharmaceuticals

(around 42 billion US $)

• Industrial Enzymes

(around 5 billion US $)

• Diagnostics

(bio-based diagnostics:
e.g. German Market
0.5 billion US $)

• Vaccines

• Biomaterials